跳至主要内容
临床试验/DRKS00016614
DRKS00016614招募中2 期

Cardiac Magnetic Resonance for the PREdiction and DIagnostiCs of hearT failure - CMRPREDICT

Institut für Biomedizinische Technik (IBT) der Universität und ETH Zürich0 个研究点目标入组 50 人开始时间: 2019年4月11日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Age of 18 years or older; signed Informed Consent Form; previously diagnosed heart failure. In a first, preliminary part of the study (pilot study, N = 5), also adults without cardiac pathologies will be enrolled.

排除标准

  • Medically unstable or acute conditions; severe claustrophobia; known or suspected allergy to Gadovist or other Gadolinium based contrast agents; moderate or worse renal insufficiency; atrioventricular block of higher degree; allergic asthma bronchiale; diabetes mellitus; implants contraindicated at 1.5T or 3.0T; pregnancy; lactation; other physical/mental/linguistic conditions incompatible with the study protocol.

研究者

发起方
Institut für Biomedizinische Technik (IBT) der Universität und ETH Zürich

相似试验